Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lung cancer screening.

Peter J Mazzone1, Tarek Mekhail

  • 1Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA. mazzonp@ccf.org

Current Oncology Reports
|June 26, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Update on diffuse idiopathic pulmonary neuroendocrine cell hyperplasia.

Current opinion in pulmonary medicine·2026
Same author

Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection-Reply.

Cancer discovery·2026
Same author

The Future of Lung Cancer Screening.

Archivos de bronconeumologia·2026
Same author

Patient preferences for EGFR mutation-targeted therapies in non-small cell lung cancer, with a focus on Exon 20 insertions.

Lung cancer (Amsterdam, Netherlands)·2025
Same author

Components Necessary for High-Quality Lung Cancer Screening: A 10-Year Update.

Chest·2025
Same author

Baseline Characteristics of Participants and Pulmonary Nodules in the Watch the Spot Trial: A Pragmatic Trial of Less versus More Intensive Strategies for Active Surveillance of Patients With Small Pulmonary Nodules.

Clinical lung cancer·2025
Same journal

Anti-PD-1 Combinations: Triplets and Beyond.

Current oncology reports·2026
Same journal

Sacituzumab Tirumotecan Across Gynecologic Malignancies: One Target, Multiple Diseases.

Current oncology reports·2026
Same journal

Clusterin in Head and Neck Squamous Cell Carcinoma: Diagnostic, Prognostic, and Therapeutic Implications.

Current oncology reports·2026
Same journal

Cardiac Risk Without a Roadmap: Lack of Evidence-Based Guidance for Cardiovascular Toxicity of T-Cell Redirecting Therapies.

Current oncology reports·2026
Same journal

Current Understanding of CHIP's Immunobiological Footprint with A Focus on Gastrointestinal Disorders: A Review of the Literature.

Current oncology reports·2026
Same journal

The Role of EZH2 ın Malıgnant Pleural Mesothelıoma and Beyond: Current Practıce and Future Perspectıves.

Current oncology reports·2026
See all related articles

Lung cancer screening aims to reduce deaths, but chest imaging studies haven't proven this yet. Key challenges include overdiagnosis and cost-effectiveness, leaving the definition of successful screening programs unclear.

Area of Science:

  • Pulmonology
  • Oncology
  • Radiology

Background:

  • Lung cancer screening programs aim to decrease lung cancer-specific mortality.
  • Current studies using chest imaging have not yet demonstrated a reduction in lung cancer mortality.

Purpose of the Study:

  • To evaluate the effectiveness of lung cancer screening programs.
  • To discuss the criteria and challenges for successful lung cancer screening.

Main Methods:

  • Review of studies evaluating chest imaging for lung cancer screening.
  • Analysis of contentious issues in screening program implementation.

Main Results:

  • No demonstrated reduction in lung cancer-specific mortality to date.
  • Debate exists regarding the ability of institutions to meet screening program criteria.

Related Experiment Videos

Conclusions:

  • Overdiagnosis bias, detection of preclinical disease, pseudodisease identification, and cost-effectiveness are critical issues.
  • Current guidelines are vague pending further randomized trials and technological advancements.
  • The definitive characteristics of a successful lung cancer screening program remain undefined.